Literature DB >> 26290423

Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.

Jonathan M DuBois1, Olivier G Rousset2, Jared Rowley3, Manuel Porras-Betancourt4, Andrew J Reader5,6, Aurelie Labbe7,8, Gassan Massarweh4, Jean-Paul Soucy4, Pedro Rosa-Neto4,3, Eliane Kobayashi9.   

Abstract

PURPOSE: Metabotropic glutamate receptor type 5 (mGluR5) is a G protein-coupled receptor that has been implicated in several psychiatric and neurological diseases. The radiopharmaceutical [(11)C]ABP688 allows for in vivo quantification of mGluR5 availability using positron emission tomography (PET). In this study, we aimed to detail the regional distribution of [(11)C]ABP688 binding potential (BPND) and the existence of age/sex effects in healthy individuals.
METHODS: Thirty-one healthy individuals aged 20 to 77 years (men, n = 18, 45.3 ± 18.2 years; females, n = 13, 41.5 ± 19.6 years) underwent imaging with [(11)C]ABP688 using the high-resolution research tomograph (HRRT). We developed an advanced partial volume correction (PVC) method using surface-based analysis in order to accurately estimate the regional variation of radioactivity. BPND was calculated using the simplified reference tissue model, with the cerebellum as the reference region. Surface-based and volume-based analyses were performed for 39 cortical and subcortical regions of interest per hemisphere.
RESULTS: We found the highest [(11)C]ABP688 BPND in the lateral prefrontal and anterior cingulate cortices. The lowest [(11)C]ABP688 BPND was observed in the pre- and post-central gyri as well as the occipital lobes and the thalami. No sex effect was observed. Associations between age and [(11)C]ABP688 BPND without PVC were observed in the right amygdala and left putamen, but were not significant after multiple comparisons correction.
CONCLUSIONS: The present results highlight complexities underlying brain adaptations during the aging process, and support the notion that certain aspects of neurotransmission remain stable during the adult life span.

Entities:  

Keywords:  Healthy controls; Metabotropic glutamate receptor 5; Positron emission tomography; [11C]ABP688

Mesh:

Substances:

Year:  2015        PMID: 26290423     DOI: 10.1007/s00259-015-3167-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  64 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Effects of aging on 5-HT(2A) R binding: a HRRT PET study with and without partial volume corrections.

Authors:  Hiroyuki Uchida; Tiffany W Chow; David C Mamo; Shitij Kapur; Benoit H Mulsant; Sylvain Houle; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2011-02-23       Impact factor: 3.485

3.  Glutamate receptors in human caudate nucleus in normal aging and Alzheimer's disease.

Authors:  Konstantinos I Tsamis; Dimitrios G Mytilinaios; Samuel N Njau; Stavros J Baloyannis
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

4.  In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.

Authors:  Antoine Leuzy; Eduardo Rigon Zimmer; Jonathan Dubois; Jens Pruessner; Cory Cooperman; Jean-Paul Soucy; Alexey Kostikov; Esther Schirmaccher; René Désautels; Serge Gauthier; Pedro Rosa-Neto
Journal:  Brain Struct Funct       Date:  2015-01-18       Impact factor: 3.270

5.  Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.

Authors:  Shil Patel; Terence G Hamill; Brett Connolly; Elaine Jagoda; Wenping Li; Raymond E Gibson
Journal:  Nucl Med Biol       Date:  2007-09-19       Impact factor: 2.408

Review 6.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

7.  Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [11 C]ABP688 PET imaging.

Authors:  William B Mathews; Hiroto Kuwabara; Kirstie Stansfield; Heather Valentine; Mohab Alexander; Anil Kumar; John Hilton; Robert F Dannals; Dean F Wong; Fabrizio Gasparini
Journal:  Synapse       Date:  2014-08-19       Impact factor: 2.562

8.  Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data.

Authors:  Douglas N Greve; Claus Svarer; Patrick M Fisher; Ling Feng; Adam E Hansen; William Baare; Bruce Rosen; Bruce Fischl; Gitte M Knudsen
Journal:  Neuroimage       Date:  2013-12-19       Impact factor: 6.556

9.  Accurate and robust brain image alignment using boundary-based registration.

Authors:  Douglas N Greve; Bruce Fischl
Journal:  Neuroimage       Date:  2009-06-30       Impact factor: 6.556

10.  Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5.

Authors:  L P Daggett; A I Sacaan; M Akong; S P Rao; S D Hess; C Liaw; A Urrutia; C Jachec; S B Ellis; J Dreessen
Journal:  Neuropharmacology       Date:  1995-08       Impact factor: 5.250

View more
  14 in total

1.  Chronic Nicotine Exposure Alters Metabotropic Glutamate Receptor 5: Longitudinal PET Study and Behavioural Assessment in Rats.

Authors:  Adrienne Müller Herde; Yoan Mihov; Stefanie D Krämer; Linjing Mu; Antoine Adamantidis; Simon M Ametamey; Gregor Hasler
Journal:  Neurotox Res       Date:  2019-05-22       Impact factor: 3.911

2.  Examining sex differences in responses to footshock stress and the role of the metabotropic glutamate receptor 5: an [18F]FPEB and positron emission tomography study in rats.

Authors:  Ruth H Asch; Santosh Pothula; Takuya Toyonaga; Krista Fowles; Stephanie M Groman; Rolando Garcia-Milian; Ralph J DiLeone; Jane R Taylor; Irina Esterlis
Journal:  Neuropsychopharmacology       Date:  2022-09-13       Impact factor: 8.294

3.  Effect of (Z)-isomer content on [11C]ABP688 binding potential in humans.

Authors:  Kelly Smart; Sylvia M L Cox; Alexey Kostikov; Aliaksandr Shalai; Stephanie G Scala; Maria Tippler; Natalia Jaworska; Michel Boivin; Jean R Séguin; Chawki Benkelfat; Marco Leyton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-03       Impact factor: 9.236

Review 4.  Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.

Authors:  Irina Esterlis; Sophie E Holmes; Priya Sharma; John H Krystal; Christine DeLorenzo
Journal:  Biol Psychiatry       Date:  2017-09-19       Impact factor: 13.382

5.  Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [18F]FPEB PET.

Authors:  Adam P Mecca; Kelly Rogers; Zachary Jacobs; Julia W McDonald; Hannah R Michalak; Nicole DellaGioia; Wenzhen Zhao; Ansel T Hillmer; Nabeel Nabulsi; Keunpoong Lim; Jim Ropchan; Yiyun Huang; David Matuskey; Irina Esterlis; Richard E Carson; Christopher H van Dyck
Journal:  Neuroimage       Date:  2021-05-27       Impact factor: 7.400

6.  Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer's dementia.

Authors:  Valerie Treyer; Anton F Gietl; Husam Suliman; Esmeralda Gruber; Rafael Meyer; Andreas Buchmann; Anass Johayem; Paul G Unschuld; Roger M Nitsch; Alfred Buck; Simon M Ametamey; Christoph Hock
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

7.  Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence.

Authors:  Ansel T Hillmer; Gustavo A Angarita; Irina Esterlis; Jon Mikael Anderson; Nabeel Nabulsi; Keunpoong Lim; Jim Ropchan; Richard E Carson; John H Krystal; Stephanie S O' Malley; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

8.  Functional Analysis of Brain Imaging Suggests Changes in the Availability of mGluR5 and Altered Connectivity in the Cerebral Cortex of Long-Term Abstaining Males with Alcohol Dependence: A Preliminary Study.

Authors:  Yo-Han Joo; Jeong-Hee Kim; Hang-Keun Kim; Young-Don Son; Paul Cumming; Jong-Hoon Kim
Journal:  Life (Basel)       Date:  2021-05-30

9.  Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.

Authors:  C DeLorenzo; J Sovago; J Gardus; J Xu; J Yang; R Behrje; J S D Kumar; D P Devanand; G H Pelton; C A Mathis; N S Mason; B Gomez-Mancilla; H Aizenstein; J J Mann; R V Parsey
Journal:  Transl Psychiatry       Date:  2015-12-08       Impact factor: 6.222

10.  Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.

Authors:  Jonathan M DuBois; Olivier G Rousset; Marie-Christine Guiot; Jeffery A Hall; Andrew J Reader; Jean-Paul Soucy; Pedro Rosa-Neto; Eliane Kobayashi
Journal:  Cereb Cortex       Date:  2016-10-17       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.